Stay updated on Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page.

Latest updates to the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the ixazomib and dexamethasone study in relapsed or refractory AL amyloidosis is displayed with its study details, results measures, participant criteria, and supporting documents.SummaryDifference100%

- Check14 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0, while the study record still shows a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH announcement says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error, leaving the study record unavailable.SummaryDifference0.2%

- Check49 days agoChange DetectedAn error page displaying '403 Forbidden' appears, replacing the study record view. The page includes a Home button, indicating the requested study page is inaccessible.SummaryDifference0.5%

Stay in the know with updates to Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page.